Research across borders

Worldwide Study Finder

Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.

Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.

Find studies Explore world registries Peptide directory

Find a study

Enter a peptide, product, condition or location. Try generic names, brand names and development codes separately. Results are registry search matches, not automatically verified links to a WPF peptide record.

Search terms are sent to ClinicalTrials.gov and appear in the page URL. Do not enter personal or medical identifying information. Registry records are served with up to a one-hour cache; registry updates themselves can lag real-world changes.

Registry search results

Matching records; showing 20 on this page, newest registry updates first. Search checked 2026-10-08 03:12 UTC. Counts are registry matches, not unique peptides or a worldwide total.

Phase 3CompletedINTERVENTIONAL

Obstructive Sleep Apnea Master Protocol GPIF: A Study of Tirzepatide (LY3298176) in Participants With Obstructive Sleep Apnea

ClinicalTrials.gov · NCT05412004 · Registry updated: 2025-04-30

Condition / research focus: Obstructive Sleep Apnea; Obesity
Sponsor: Eli Lilly and Company
Countries with listed sites: Australia · Brazil · China · Czechia · Germany · Japan · Mexico · Puerto Rico · Taiwan · United States
Registry dates and results: Start: 2022-06-21. Completion: 2024-03-29 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Tirzepatide (drug) — also listed as: LY3298176
Placebo (drug)

Where the study takes place — 58 listed sites

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

Artemis Institute for Clinical Research
Riverside, California, United States
Site recruitment: Not reported
Teradan Clinical Trials, LLC
Brandon, Florida, United States
Site recruitment: Not reported
Renstar Medical Research
Ocala, Florida, United States
Site recruitment: Not reported
Palm Beach Research Center
West Palm Beach, Florida, United States
Site recruitment: Not reported
NeuroTrials Research Inc
Atlanta, Georgia, United States
Site recruitment: Not reported
Rocky Mountain Clinical Research
Idaho Falls, Idaho, United States
Site recruitment: Not reported
Brengle Family Medicine
Indianapolis, Indiana, United States
Site recruitment: Not reported
Lillestol Research
Fargo, North Dakota, United States
Site recruitment: Not reported
NeuroScience Research Center
Canton, Ohio, United States
Site recruitment: Not reported
CTI-CRC
Cincinnati, Ohio, United States
Site recruitment: Not reported
Office 18
Pittsburgh, Pennsylvania, United States
Site recruitment: Not reported
Preferred Primary Care Physicians
Uniontown, Pennsylvania, United States
Site recruitment: Not reported
FutureSearch Trials of Neurology
Austin, Texas, United States
Site recruitment: Not reported
Gadolin Research
Beaumont, Texas, United States
Site recruitment: Not reported
Advanced Neuro Research Center - ANRC
El Paso, Texas, United States
Site recruitment: Not reported
Epic Medical Research
Red Oak, Texas, United States
Site recruitment: Not reported
Sleep Therapy Research Center
San Antonio, Texas, United States
Site recruitment: Not reported
Rainier Clinical Research Center
Renton, Washington, United States
Site recruitment: Not reported
Woolcock Institute of Medical Research
Sydney, New South Wales, Australia
Site recruitment: Not reported
Flinders University
Bedford Park, South Australia, Australia
Site recruitment: Not reported
Núcleo de Pesquisa Clínica do Rio Grande do Sul
Porto Alegre, Rio Grande do Sul, Brazil
Site recruitment: Not reported
CPCLIN
São Paulo, São Paulo, Brazil
Site recruitment: Not reported
CPQuali Pesquisa Clínica
São Paulo, Brazil
Site recruitment: Not reported
Hospital das Clinicas FMUSP
São Paulo, Brazil
Site recruitment: Not reported
BR Trials - Ensaios Clinicos e Consultoria
São Paulo, Brazil
Site recruitment: Not reported
Hospital das Clinicas FMUSP
São Paulo, Brazil
Site recruitment: Not reported
The Second Affiliated Hospital of Nanjing Medical University
Nanjing, Jiangsu, China
Site recruitment: Not reported
Wuxi People's Hospital
Wuxi, Jiangsu, China
Site recruitment: Not reported
The First Hospital of Jilin University
Changchun, Jilin, China
Site recruitment: Not reported
Zhongshan Hospital,Fudan University
Shanghai, Shanghai Municipality, China
Site recruitment: Not reported
West China Hospital, Sichuan University
Chengdu, Sichuan, China
Site recruitment: Not reported
Tianjin Medical University General Hospital
Tianjin, Tianjin Municipality, China
Site recruitment: Not reported
Vseobecna fakultni nemocnice v Praze
Prague, Czechia
Site recruitment: Not reported
Praglandia s.r.o
Prague, Czechia
Site recruitment: Not reported
Siteworks GmbH
Hanover, Lower Saxony, Germany
Site recruitment: Not reported
InnoDiab Forschung Gmbh
Essen, North Rhine-Westphalia, Germany
Site recruitment: Not reported
Institut für Diabetesforschung GmbH Münster
Münster, North Rhine-Westphalia, Germany
Site recruitment: Not reported
RED-Institut GmbH
Oldenburg in Holstein, Schleswig-Holstein, Germany
Site recruitment: Not reported
Lungenpraxis Schleswig
Schleswig, Schleswig-Holstein, Germany
Site recruitment: Not reported
Advanced Sleep Research
Berlin, Germany
Site recruitment: Not reported
Diabeteszentrum Hamburg West
Hamburg, Germany
Site recruitment: Not reported
Koujunkai Daido Clinic
Nagoya, Aichi-ken, Japan
Site recruitment: Not reported
Kirigaokatsuda Hospital
Kitakyushu, Fukuoka, Japan
Site recruitment: Not reported
RESM Respiratory and Sleep Medical Care Clinic
Yokohama, Kanagawa, Japan
Site recruitment: Not reported
Sakai City Medical Center
Sakai, Osaka, Japan
Site recruitment: Not reported
Fukuwa Clinic
Chuo-ku, Tokyo, Japan
Site recruitment: Not reported
Osaka Kaisei Hospital
Osaka, Japan
Site recruitment: Not reported
Private Practice - Dr. Arechavaleta Granell Maria del Rosario
Guadalajara, Jalisco, Mexico
Site recruitment: Not reported
Unidad de Investigación Clínica y Atención Médica HEPA
Guadalajara, Jalisco, Mexico
Site recruitment: Not reported
RM Pharma Specialists
Mexico City, Mexico City, Mexico
Site recruitment: Not reported
Centro Especializado En Diabetes, Obesidad Y Prevencion De Enfermedades Cardiovasculares
Mexico City, Mexico City, Mexico
Site recruitment: Not reported
Servicios Integrales Nova de Monterrey S.A. de C.V.
San Nicolás de los Garza, Nuevo León, Mexico
Site recruitment: Not reported
Unidad Médica para la Salud Integral
San Nicolás de los Garza, Nuevo León, Mexico
Site recruitment: Not reported
Investigacion En Salud Y Metabolismo Sc
Chihuahua City, Mexico
Site recruitment: Not reported
Arké SMO S.A de C.V
Veracruz, Mexico
Site recruitment: Not reported
Puerto Rico Medical Research Center
Hato Rey, Puerto Rico, Puerto Rico
Site recruitment: Not reported
China Medical University Hospital
Taichung, Taiwan
Site recruitment: Not reported
National Cheng Kung University Hospital
Tainan, Taiwan
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4RecruitingINTERVENTIONAL

Subcutaneous Tirzepatide Once-weekly in Patients With Obesity and Knee Osteoarthritis (STOP KNEE-OA)

ClinicalTrials.gov · NCT06191848 · Registry updated: 2025-04-30

Condition / research focus: Obesity; Knee Osteoarthritis; Osteoarthritis, Knee
Sponsor: University of Melbourne
Countries with listed sites: Australia
Registry dates and results: Start: 2024-11-19. Completion: 2037-05 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Tirzepatide (drug)
Placebo (drug)

Where the study takes place — 4 listed sites

St Vincents Hospital Melbourne
Fitzroy, Victoria, Australia
Site recruitment: Recruiting
Western Health
Melbourne, Victoria, Australia
Site recruitment: Recruiting
Austin Health-Repatriation Hospital
Melbourne, Victoria, Australia
Site recruitment: Recruiting
Eastern Health
Melbourne, Victoria, Australia
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 1CompletedINTERVENTIONAL

A Study of Tirzepatide (LY3298176) in Healthy Lactating Females

ClinicalTrials.gov · NCT05978713 · Registry updated: 2025-04-27

Condition / research focus: Healthy
Sponsor: Eli Lilly and Company
Countries with listed sites: United States
Registry dates and results: Start: 2023-07-31. Completion: 2024-03-12 (may be estimated). Results are posted in this registry.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Tirzepatide (drug) — also listed as: LY3298176

Where the study takes place — 1 listed sites

Las Vegas Clinical Research Unit - PPD
Las Vegas, Nevada, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3Active, not recruitingINTERVENTIONAL

Efficacy and Safety of Tirzepatide for Weight Management

ClinicalTrials.gov · NCT06918405 · Registry updated: 2025-04-09

Condition / research focus: Obesity and Obesity-related Medical Conditions
Sponsor: Chittagong Medical College
Countries with listed sites: Bangladesh
Registry dates and results: Start: 2025-01-01. Completion: 2026-06-30 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Tirzepatide (drug)

Where the study takes place — 1 listed sites

Chittagong Medical College Hospital
Chittagong, Bangladesh
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableRecruitingINTERVENTIONAL

MAINTAIN (Mucosal AblatIoN Therapy After INcretins)

ClinicalTrials.gov · NCT06734312 · Registry updated: 2025-03-21

Condition / research focus: Obesity and Obesity-related Medical Conditions; Obesity and Overweight; Obesity Prevention; Obesity Recidivism; GLP-1; Ablation Techniques
Sponsor: Dr. Christopher McGowan
Countries with listed sites: United States
Registry dates and results: Start: 2025-01-01. Completion: 2026-06 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Gastric Fundal Mucosal Ablation (GFMA) (device)

Where the study takes place — 2 listed sites

True You Weight Loss
Cary, North Carolina, United States
Site recruitment: Not yet recruiting
True You Weight Loss
Cary, North Carolina, United States
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 2TerminatedINTERVENTIONAL

Efficacy and Safety of Oral Azelaprag Plus Once Weekly Tirzepatide Compared with Tirzepatide Alone in Participants with Obesity Aged 55 Years and Over

ClinicalTrials.gov · NCT06515418 · Registry updated: 2025-03-13

Condition / research focus: Obesity
Sponsor: BioAge Labs, Inc.
Countries with listed sites: United States
Registry dates and results: Start: 2024-06-27. Completion: 2025-02-12 (may be estimated). No results posted in this registry response.

Products and interventions (4)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oral Azelaprag (BGE-105) (drug) — also listed as: BGE-105
Oral Placebo for Azelaprag (BGE-105) (drug) — also listed as: Placebo
Tirzepatide (drug)
Tirzepatide Placebo (drug)

Where the study takes place — 14 listed sites

Site 110
Mesa, Arizona, United States
Site recruitment: Not reported
Site 107
Los Angeles, California, United States
Site recruitment: Not reported
Site 103
Montclair, California, United States
Site recruitment: Not reported
Site 105
Spring Valley, California, United States
Site recruitment: Not reported
Site 100
Louisville, Kentucky, United States
Site recruitment: Not reported
Site 101
Marrero, Louisiana, United States
Site recruitment: Not reported
Site 112
Boston, Massachusetts, United States
Site recruitment: Not reported
Site 111
Troy, Michigan, United States
Site recruitment: Not reported
Site 113
City of Saint Peters, Missouri, United States
Site recruitment: Not reported
Site 106
Butte, Montana, United States
Site recruitment: Not reported
Site 109
Fargo, North Dakota, United States
Site recruitment: Not reported
Site 108
Beachwood, Ohio, United States
Site recruitment: Not reported
Site 102
Dallas, Texas, United States
Site recruitment: Not reported
Site 104
St. George, Utah, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2Active, not recruitingINTERVENTIONAL

A Phase 2 Study Evaluating the Co-Administration of Bremelanotide With Tirzepatide for the Treatment of Obesity

ClinicalTrials.gov · NCT06565611 · Registry updated: 2025-03-06

Condition / research focus: Obesity
Sponsor: Palatin Technologies, Inc
Countries with listed sites: United States
Registry dates and results: Start: 2024-08-05. Completion: 2025-03-31 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

bremelanotide (drug)
tirzepatide (drug)

Where the study takes place — 4 listed sites

University Clinical Research-DeLand LLC, d/b/a Accel Research
DeLand, Florida, United States
Site recruitment: Not reported
Lynn Health Science Institute
Oklahoma City, Oklahoma, United States
Site recruitment: Not reported
Coastal Carolina Research Center
North Charleston, South Carolina, United States
Site recruitment: Not reported
Lynn Institute of Chattanooga
Chattanooga, Tennessee, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableNot yet recruitingOBSERVATIONAL

Impact of Antiobesity Medications on Appetite and Appetite-related Hormones and Metabolites.

ClinicalTrials.gov · NCT06856928 · Registry updated: 2025-03-04

Condition / research focus: Obesity; Drug
Sponsor: University of Colorado, Denver
Countries with listed sites: No country reported
Registry dates and results: Start: 2025-03. Completion: 2027-12 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Meal Challenge (other)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase 4WithdrawnINTERVENTIONAL

Effects of Tirzepatide Plus Intensive Lifestyle Therapy on Body Weight and Metabolic Health in Latinos With Obesity

ClinicalTrials.gov · NCT06009653 · Registry updated: 2025-02-25

Condition / research focus: Obesity; Metabolic Disease
Sponsor: Washington University School of Medicine
Countries with listed sites: United States
Registry dates and results: Start: 2023-09-13. Completion: 2024-05-29 (may be estimated). No results posted in this registry response.

Products and interventions (4)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Standard Care (behavioral)
Culturally-tailored dietary and behavioral intensive lifestyle intervention (behavioral)
Placebo (drug)
Tirzepatide (drug)

Where the study takes place — 1 listed sites

Sansum Diabetes Research Institute
Santa Barbara, California, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2CompletedINTERVENTIONAL

Study That Tests AD109 in Patients Taking GLP-1 Drugs

ClinicalTrials.gov · NCT06400615 · Registry updated: 2025-02-19

Condition / research focus: OSA
Sponsor: Apnimed
Countries with listed sites: United States
Registry dates and results: Start: 2024-05-20. Completion: 2024-12-26 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

AD109 (drug)

Where the study takes place — 4 listed sites

Pinnacle Research Group, LLC
Anniston, Alabama, United States
Site recruitment: Not reported
Clinical Neuroscience Solutions, Inc
Jacksonville, Florida, United States
Site recruitment: Not reported
Monroe Biomedical Research
Monroe, North Carolina, United States
Site recruitment: Not reported
Clinical Neuroscience Solutions, Inc
Memphis, Tennessee, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4WithdrawnINTERVENTIONAL

Gastric Sleeve-Induced Weight Loss on Shortness of Breath in Obesity

ClinicalTrials.gov · NCT05812183 · Registry updated: 2025-02-14

Condition / research focus: Dyspnea; Quality of Life
Sponsor: University of California, Los Angeles
Countries with listed sites: No country reported
Registry dates and results: Start: 2023-07-09. Completion: 2025-02-12 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Bariatric surgery (device)
Medical weight loss (drug)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase 2CompletedINTERVENTIONAL

A Study of Tirzepatide (LY3298176) in Participants With Nonalcoholic Steatohepatitis (NASH)

ClinicalTrials.gov · NCT04166773 · Registry updated: 2025-01-24

Condition / research focus: Nonalcoholic Steatohepatitis
Sponsor: Eli Lilly and Company
Countries with listed sites: Belgium · France · Israel · Italy · Japan · Mexico · Poland · Spain · United Kingdom · United States
Registry dates and results: Start: 2019-11-19. Completion: 2024-01-10 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Tirzepatide (drug) — also listed as: LY3298176
Placebo (drug)

Where the study takes place — 112 listed sites

University of Alabama-The Kirklin Clinic
Birmingham, Alabama, United States
Site recruitment: Not reported
Synexus Clinical Research US, Inc.
Chandler, Arizona, United States
Site recruitment: Not reported
Fresno Clinical Research Center
Fresno, California, United States
Site recruitment: Not reported
National Research Institute - Huntington Park
Huntington Park, California, United States
Site recruitment: Not reported
UCSD - Altman Clinical and Translational Research Institute (ACTRI)
La Jolla, California, United States
Site recruitment: Not reported
National Research Institute - Wilshire
Los Angeles, California, United States
Site recruitment: Not reported
Catalina Research Institute, LLC
Montclair, California, United States
Site recruitment: Not reported
Diabetes Medical Center of California
Northridge, California, United States
Site recruitment: Not reported
Velocity Clinical Research, Panorama City
Panorama City, California, United States
Site recruitment: Not reported
Inland Empire Clinical Trials, LLC
Rialto, California, United States
Site recruitment: Not reported
Velocity Clinical Research, Santa Ana
Santa Ana, California, United States
Site recruitment: Not reported
Excel Medical Clinical Trials
Boca Raton, Florida, United States
Site recruitment: Not reported
Alliance for Multispecialty Research, LLC
Coral Gables, Florida, United States
Site recruitment: Not reported
Research Centers of America ( Hollywood )
Hollywood, Florida, United States
Site recruitment: Not reported
East Coast Institute for Research, LLC
Jacksonville, Florida, United States
Site recruitment: Not reported
IHS Health Research
Kissimmee, Florida, United States
Site recruitment: Not reported
Accel Research Sites - Maitland Clinical Research Unit
Maitland, Florida, United States
Site recruitment: Not reported
Clinical Pharmacology of Miami
Miami, Florida, United States
Site recruitment: Not reported
The Center for Digestive Health
Orlando, Florida, United States
Site recruitment: Not reported
Synexus Clinical Research US, Inc.
Orlando, Florida, United States
Site recruitment: Not reported
Synexus Clinical Research US, Inc.
The Villages, Florida, United States
Site recruitment: Not reported
Synexus Clinical Research
Chicago, Illinois, United States
Site recruitment: Not reported
Indiana University Health Hospital
Indianapolis, Indiana, United States
Site recruitment: Not reported
Iowa Diabetes and Endocrinology Research Center
West Des Moines, Iowa, United States
Site recruitment: Not reported
Cotton O'Neil Clinical Research Center
Topeka, Kansas, United States
Site recruitment: Not reported
Alliance for Multispecialty Research, LLC
Wichita, Kansas, United States
Site recruitment: Not reported
Tandem Clinical Research
Marrero, Louisiana, United States
Site recruitment: Not reported
The National Diabetes & Obesity Research Institute
Biloxi, Mississippi, United States
Site recruitment: Not reported
Southern Therapy and Advanced Research (STAR) LLC
Jackson, Mississippi, United States
Site recruitment: Not reported
Buffalo Clinical and Translational Research Center
Buffalo, New York, United States
Site recruitment: Not reported
NYU Langone Health
New York, New York, United States
Site recruitment: Not reported
Icahn School of Medicine at Mount Sinai
New York, New York, United States
Site recruitment: Not reported
Montefiore Medical Center
The Bronx, New York, United States
Site recruitment: Not reported
Diabetes & Endocrinology Consultants, PC
Morehead City, North Carolina, United States
Site recruitment: Not reported
Geisinger Medical Center
Danville, Pennsylvania, United States
Site recruitment: Not reported
WR-Clinsearch, LLC
Chattanooga, Tennessee, United States
Site recruitment: Not reported
Dallas Diabetes Research Center
Dallas, Texas, United States
Site recruitment: Not reported
Radiant Research - Dallas North
Dallas, Texas, United States
Site recruitment: Not reported
Liver Center of Texas, PLLC
Dallas, Texas, United States
Site recruitment: Not reported
Texoma Medical Center
Denison, Texas, United States
Site recruitment: Not reported
Texas Diabetes & Endocrinology, P.A.
Round Rock, Texas, United States
Site recruitment: Not reported
American Research Corporation at Texas Liver Institute
San Antonio, Texas, United States
Site recruitment: Not reported
Synexus Clinical Research US, Inc.
San Antonio, Texas, United States
Site recruitment: Not reported
Endeavor Clinical Trials
San Antonio, Texas, United States
Site recruitment: Not reported
National Clinical Research, Inc
Richmond, Virginia, United States
Site recruitment: Not reported
Virginia Commonwealth University (VCU) Medical Center
Richmond, Virginia, United States
Site recruitment: Not reported
Harborview Medical Center/University of Washington
Seattle, Washington, United States
Site recruitment: Not reported
Antwerp University Hospital
Edegem, Antwerpen, Belgium
Site recruitment: Not reported
UZ Brussel
Brussels, Bruxelles-Capitale, Région de, Belgium
Site recruitment: Not reported
UZ Gent
Ghent, Oost-Vlaanderen, Belgium
Site recruitment: Not reported
UZ Leuven
Leuven, Vlaams-Brabant, Belgium
Site recruitment: Not reported
AZ Delta vzw
Roeselare, West-Vlaanderen, Belgium
Site recruitment: Not reported
CHU Bordeaux Haut-Leveque
Pessac, Aquitaine, France
Site recruitment: Not reported
Groupe Hospitalier Mutualiste Les Portes du Sud
Vénissieux, Auvergne-Rhône-Alpes, France
Site recruitment: Not reported
Centre Hospitalier Universitaire de Limoges - Hôpital Dupuytren
Limoges, Haute-Vienne, France
Site recruitment: Not reported
Centre Hospitalier Universitaire d'Angers
Angers, Maine-et-Loire, France
Site recruitment: Not reported
Centre Hospitalier Lyon Sud
Pierre-Bénite, Rhône, France
Site recruitment: Not reported
Pitie Salpetriere University Hospital
Paris, France
Site recruitment: Not reported
Hôpital Saint Antoine
Paris, France
Site recruitment: Not reported
Sheba Medical Center
Ramat Gan, Central District, Israel
Site recruitment: Not reported
Hadassah Medical Center
Jerusalem, Jerusalem, Israel
Site recruitment: Not reported
Shaare Zedek Medical Center
Jerusalem, Jerusalem, Israel
Site recruitment: Not reported
Rambam Health Care Campus
Haifa, Northern District, Israel
Site recruitment: Not reported
Galilee Medical Center
Nahariya, Northern District, Israel
Site recruitment: Not reported
Carmel Hospital
Haifa, Israel
Site recruitment: Not reported
A.O.U. Policlinico Paolo Giaccone
Palermo, Sicily, Italy
Site recruitment: Not reported
Azienda Ospedaliero Universitaria Ospedali Riuniti Di Foggia
Foggia, Italy
Site recruitment: Not reported
Ospedale Santa Maria Goretti
Latina, Italy
Site recruitment: Not reported
Fondazione Policlinico Universitario Agostino Gemelli
Roma, Italy
Site recruitment: Not reported
Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino
Torino, Italy
Site recruitment: Not reported
Aichi Medical University Hospital
Nagakute-shi, Aichi-ken, Japan
Site recruitment: Not reported
JCHO Hokkaido Hospital
Sapporo, Hokkaido, Japan
Site recruitment: Not reported
Yokohama City University Hospital
Yokohama, Kanagawa, Japan
Site recruitment: Not reported
National Hospital Organization Yokohama Medical Center
Yokohama, Kanagawa, Japan
Site recruitment: Not reported
JADECOM Nara City Hospital
Nara, Nara, Japan
Site recruitment: Not reported
Hirakata kohsai Hospital
Higashi-cho, Hirakata-city, Osaka, Japan
Site recruitment: Not reported
Osaka Saiseikai Suita hospital
Suita, Osaka, Japan
Site recruitment: Not reported
Shimane University Hospital
Izumo, Shimane, Japan
Site recruitment: Not reported
Tokyo Medical And Dental University Medical Hospital
Bunkyō, Tokyo, Japan
Site recruitment: Not reported
Fukuiken Saiseikai Hospital
Fukui, Japan
Site recruitment: Not reported
Gifu Municipal Hospital
Gifu, Japan
Site recruitment: Not reported
Kumamoto Shinto General Hospital
Kumamoto, Japan
Site recruitment: Not reported
University Hospital,Kyoto Prefectural University of Medicine
Kyoto, Japan
Site recruitment: Not reported
Niigata University Medical & Dental Hospital
Niigata, Japan
Site recruitment: Not reported
Saga University Hospital
Saga, Japan
Site recruitment: Not reported
Yamagata University Hospital
Yamagata, Japan
Site recruitment: Not reported
Phylasis Clinicas Research
Cuautitlan Izcalli, Mexico City, Mexico
Site recruitment: Not reported
Grupo Medico Camino Sc
Mexico City, Mexico City, Mexico
Site recruitment: Not reported
Christus Muguerza Hospital Sur
Monterrey, Nuevo León, Mexico
Site recruitment: Not reported
Centro de Investigación y Gastroenterología
Cuauhtémoc, Mexico
Site recruitment: Not reported
Synexus Polska Sp. z o.o. Oddzial w Warszawie
Warsaw, Masovian Voivodeship, Poland
Site recruitment: Not reported
Synexus Polska Oddział w Lodzi
Lodz, Łódź Voivodeship, Poland
Site recruitment: Not reported
Clínica Juaneda
Palma de Mallorca, Balears [Baleares], Spain
Site recruitment: Not reported
Hospital Universitario Marqués de Valdecilla
Santander, Cantabria, Spain
Site recruitment: Not reported
Hospital Universitario Ramón y Cajal
Madrid, Madrid, Comunidad de, Spain
Site recruitment: Not reported
Instituto de Ciencias Médicas
Alicante, Spain
Site recruitment: Not reported
Hospital Universitario Puerta de Hierro Majadahonda
Madrid, Spain
Site recruitment: Not reported
Clínica nuevas Tecnologías en Diabetes y Endocrinología (NTDE)
Seville, Spain
Site recruitment: Not reported
Hospital Universitario Virgen Del Rocio
Seville, Spain
Site recruitment: Not reported
Queen Elizabeth Hospital Birmingham
Birmingham, England, United Kingdom
Site recruitment: Not reported
Synexus North East Clinical Research Centre
Hexham, England, United Kingdom
Site recruitment: Not reported
Royal London Hospital
London, England, United Kingdom
Site recruitment: Not reported
St. George's Hospital
London, England, United Kingdom
Site recruitment: Not reported
Synexus Clinical Research Centre - Lancashire
Chorley, Lancashire, United Kingdom
Site recruitment: Not reported
King's College Hospital
London, London, City of, United Kingdom
Site recruitment: Not reported
Queen's Medical Centre, Nottingham University Hospitals
Nottingham, Nottinghamshire, United Kingdom
Site recruitment: Not reported
John Radcliffe Hospital
Headington, Oxford, United Kingdom
Site recruitment: Not reported
Synexus North Teesside Clinical Research Centre
Stockton-on-Tees, Stockton-on-Tees, United Kingdom
Site recruitment: Not reported
Imperial College London - St Mary's Hospital
London, Westminster, United Kingdom
Site recruitment: Not reported
Synexus Midlands Clinical Research Centre
Birmingham, United Kingdom
Site recruitment: Not reported
Aintree University Hospital NHS Foundation Trust
Liverpool, United Kingdom
Site recruitment: Not reported
Synexus Manchester Clinical Research Centre
Manchester, United Kingdom
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

A Study to Determine the Feasibility of Online Recruitment of People Using an Anti-Obesity Medication for Weight Loss

ClinicalTrials.gov · NCT06761703 · Registry updated: 2025-01-14

Condition / research focus: Obesity
Sponsor: Amgen
Countries with listed sites: United States
Registry dates and results: Start: 2024-11-14. Completion: 2025-01-06 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

TAP® Micro Select Device (Touch Activated Phlebotomy) (device)

Where the study takes place — 1 listed sites

YourBio Health/CRT
Medford, Massachusetts, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

A Study of Tirzepatide (LY3298176) in Adults With Type 2 Diabetes Switching From a GLP-1 RA (SURPASS-SWITCH-2)

ClinicalTrials.gov · NCT05706506 · Registry updated: 2024-12-13

Condition / research focus: Type 2 Diabetes; Diabetes Mellitus, Type 2
Sponsor: Eli Lilly and Company
Countries with listed sites: United States
Registry dates and results: Start: 2023-03-08. Completion: 2023-10-31 (may be estimated). Results are posted in this registry.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Tirzepatide (drug) — also listed as: LY3298176

Where the study takes place — 32 listed sites

Fiel Family and Sports Medicine PC
Tempe, Arizona, United States
Site recruitment: Not reported
New Hope Research Development
Corona, California, United States
Site recruitment: Not reported
Velocity Clinical Research, Gardena
Gardena, California, United States
Site recruitment: Not reported
Velocity Clinical Research, Huntington Park
Huntington Park, California, United States
Site recruitment: Not reported
Velocity Clinical Research, Huntington Park
Los Angeles, California, United States
Site recruitment: Not reported
Valley Clinical Trials, Inc.
Northridge, California, United States
Site recruitment: Not reported
Dream Team Clinical Research
Pomona, California, United States
Site recruitment: Not reported
Scripps Whittier Diabetes Institute
San Diego, California, United States
Site recruitment: Not reported
Metabolic Institute of America
Tarzana, California, United States
Site recruitment: Not reported
CMR of Greater New Haven, LLC
Waterbury, Connecticut, United States
Site recruitment: Not reported
Velocity Clinical Research, Hallandale Beach
Hallandale, Florida, United States
Site recruitment: Not reported
East Coast Institute for Research, LLC
Jacksonville, Florida, United States
Site recruitment: Not reported
Florida Institute For Clinical Research, LLC
Orlando, Florida, United States
Site recruitment: Not reported
New Tampa Health
Tampa, Florida, United States
Site recruitment: Not reported
Georgia Clinical Research
Lawrenceville, Georgia, United States
Site recruitment: Not reported
Endocrine Research Solutions, Inc.
Roswell, Georgia, United States
Site recruitment: Not reported
Velocity Clinical Research, Valparaiso
Valparaiso, Indiana, United States
Site recruitment: Not reported
Iowa Diabetes and Endocrinology Research Center
West Des Moines, Iowa, United States
Site recruitment: Not reported
Cotton O'Neil Clinic
Topeka, Kansas, United States
Site recruitment: Not reported
Versailles Family Medicine
Versailles, Kentucky, United States
Site recruitment: Not reported
Endocrine and Metabolic Consultants
Rockville, Maryland, United States
Site recruitment: Not reported
Clinical Research Professionals
Chesterfield, Missouri, United States
Site recruitment: Not reported
Clinical Research of South Nevada
Las Vegas, Nevada, United States
Site recruitment: Not reported
Palm Research Center Tenaya
Las Vegas, Nevada, United States
Site recruitment: Not reported
Advanced Medical Research
Maumee, Ohio, United States
Site recruitment: Not reported
Conrad Clinical Research
Edmond, Oklahoma, United States
Site recruitment: Not reported
Mountain View Clinical Research, Inc.
Greenville, South Carolina, United States
Site recruitment: Not reported
Texas Diabetes & Endocrinology, P.A.
Austin, Texas, United States
Site recruitment: Not reported
North Texas Endocrine Center
Dallas, Texas, United States
Site recruitment: Not reported
Memorial City Endocrine Consultants
Houston, Texas, United States
Site recruitment: Not reported
Consano Clinical Research, LLC
Shavano Park, Texas, United States
Site recruitment: Not reported
ClinPoint Trials
Waxahachie, Texas, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2RecruitingINTERVENTIONAL

Tirzepatide: Reversal of Lipotoxicity and Adipose Tissue Dysfunction in Humans With Overweight/Obesity

ClinicalTrials.gov · NCT05912621 · Registry updated: 2024-12-04

Condition / research focus: Obesity; Overweight and Obesity; Overweight
Sponsor: Stanford University
Countries with listed sites: United States
Registry dates and results: Start: 2023-11-09. Completion: 2029-12 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Tirzepatide (drug) — also listed as: Mounjaro

Where the study takes place — 1 listed sites

Clinical and Translational Research Unit
Palo Alto, California, United States
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 4RecruitingINTERVENTIONAL

Effect of Tirzepatide on Progression of Coronary Atherosclerosis Using MDCT

ClinicalTrials.gov · NCT05708859 · Registry updated: 2024-10-15

Condition / research focus: Type II Diabetes; Atherosclerosis
Sponsor: Matthew J. Budoff
Countries with listed sites: United States
Registry dates and results: Start: 2024-01-02. Completion: 2026-05 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Tirzepatide (drug) — also listed as: Mounjaro
Placebo (drug)

Where the study takes place — 1 listed sites

Lundquist Institute for Biomedical Innovation at Harbor UCLA Medical Center (The Lundquist Institute)
Torrance, California, United States
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 1CompletedINTERVENTIONAL

A Research Study Looking at Similarity Between Tirzepatide Versions for Different Injection Devices

ClinicalTrials.gov · NCT05810597 · Registry updated: 2024-10-15

Condition / research focus: Healthy
Sponsor: Eli Lilly and Company
Countries with listed sites: United States
Registry dates and results: Start: 2023-04-03. Completion: 2023-07-17 (may be estimated). Results are posted in this registry.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Tirzepatide (drug) — also listed as: LY3298176
Single Dose Pen (device)
Multi-use Prefilled Pen (device)

Where the study takes place — 3 listed sites

Qps-Mra, Llc
South Miami, Florida, United States
Site recruitment: Not reported
ICON Early Phase Services
San Antonio, Texas, United States
Site recruitment: Not reported
ICON
Salt Lake City, Utah, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

A Study of Tirzepatide (LY3298176) in Participants With Obesity Disease

ClinicalTrials.gov · NCT04844918 · Registry updated: 2024-07-16

Condition / research focus: Obesity
Sponsor: Eli Lilly and Company
Countries with listed sites: Japan
Registry dates and results: Start: 2021-05-10. Completion: 2023-06-24 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Tirzepatide (drug) — also listed as: LY3298176
Placebo (other)

Where the study takes place — 18 listed sites

Kohnodai Hospital, National Center for Global Health and Medicine
Ichikawa, Chiba, Japan
Site recruitment: Not reported
Saiseikai Matsuyama Hospital
Matsuyama, Ehime, Japan
Site recruitment: Not reported
Takai Internal Medicine Clinic
Kamakura-shi, Kanagawa, Japan
Site recruitment: Not reported
Saiseikai Yokohamashi Tobu Hospital
Yokohama, Kanagawa, Japan
Site recruitment: Not reported
Motomachi Takatsuka Naika Clinic
Yokohama, Kanagawa, Japan
Site recruitment: Not reported
Osaka Saiseikai Suita hospital
Suita, Osaka, Japan
Site recruitment: Not reported
Medical Corporation Heishinkai OCROM Clinic
Suita-shi, Osaka, Japan
Site recruitment: Not reported
Takatsuki Red Cross Hospital
Takatsuki, Osaka, Japan
Site recruitment: Not reported
The Institute for Adult Disease, Asahi Life Foundation
Chuo-ku, Tokyo, Japan
Site recruitment: Not reported
Tokyo-Eki Center-building Clinic
Chuo-ku, Tokyo, Japan
Site recruitment: Not reported
Medical Corporation Chiseikai Tokyo Center Clinic
Chuo-ku, Tokyo, Japan
Site recruitment: Not reported
Fukuwa Clinic
Chuo-ku, Tokyo, Japan
Site recruitment: Not reported
Saiseikai Central Hospital
Minato-Ku, Tokyo, Japan
Site recruitment: Not reported
Shimokitazawa Tomo Clinic
Setagaya-ku, Tokyo, Japan
Site recruitment: Not reported
Miho Clinic
Shinagawa-ku, Tokyo, Japan
Site recruitment: Not reported
Medical Corporation Heishinkai ToCROM Clinic
Shinjuku-ku, Tokyo, Japan
Site recruitment: Not reported
Yamagata Tokushukai Hospital
Yamagata, Yamagata, Japan
Site recruitment: Not reported
AMC Nishiumeda Clinic
Osaka, Japan
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Role Of Metabolic Adaptation In Weight Regain

ClinicalTrials.gov · NCT05766358 · Registry updated: 2024-06-10

Condition / research focus: Weight Loss; Weight Gain; Obesity
Sponsor: Pennington Biomedical Research Center
Countries with listed sites: United States
Registry dates and results: Start: 2022-10-06. Completion: 2024-05-24 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Intensive lifestyle change therapy (behavioral)
Tirzepatide (drug)

Where the study takes place — 1 listed sites

Pennington Biomedical Research Center
Baton Rouge, Louisiana, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight for the Maintenance of Weight Loss

ClinicalTrials.gov · NCT04660643 · Registry updated: 2024-05-22

Condition / research focus: Obesity; Overweight
Sponsor: Eli Lilly and Company
Countries with listed sites: Argentina · Brazil · Puerto Rico · Taiwan · United States
Registry dates and results: Start: 2021-03-29. Completion: 2023-05-18 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Tirzepatide (drug) — also listed as: LY3298176
Placebo (other)

Where the study takes place — 70 listed sites

Cahaba Research
Pelham, Alabama, United States
Site recruitment: Not reported
Scripps Memorial Hospital La Jolla
La Jolla, California, United States
Site recruitment: Not reported
National Research Institute - Wilshire
Los Angeles, California, United States
Site recruitment: Not reported
National Research Institute
Panorama City, California, United States
Site recruitment: Not reported
Artemis Institute for Clinical Research
San Diego, California, United States
Site recruitment: Not reported
University Clinical Investigators, Inc.
Tustin, California, United States
Site recruitment: Not reported
New West Physicians Clinical Research
Golden, Colorado, United States
Site recruitment: Not reported
Optumcare Colorado Springs - Monument
Monument, Colorado, United States
Site recruitment: Not reported
Care Partners Clinical Research
Jacksonville, Florida, United States
Site recruitment: Not reported
South Florida Clinical Research Institute
Margate, Florida, United States
Site recruitment: Not reported
Renstar Medical Research
Ocala, Florida, United States
Site recruitment: Not reported
ForCare Clinical Research
Tampa, Florida, United States
Site recruitment: Not reported
Endocrine Research Solutions, Inc.
Roswell, Georgia, United States
Site recruitment: Not reported
SKY Clinical Research Network Group-Blake
Union City, Georgia, United States
Site recruitment: Not reported
East-West Medical Research Institute
Honolulu, Hawaii, United States
Site recruitment: Not reported
Rocky Mountain Clinical Research
Idaho Falls, Idaho, United States
Site recruitment: Not reported
Healthcare Research Network - Chicago
Flossmoor, Illinois, United States
Site recruitment: Not reported
Clinical Investigation Specialists
Gurnee, Illinois, United States
Site recruitment: Not reported
Midwest Institute For Clinical Research
Indianapolis, Indiana, United States
Site recruitment: Not reported
American Health Network of Indiana, LLC - New Albany
New Albany, Indiana, United States
Site recruitment: Not reported
Cotton O'Neil Clinic
Topeka, Kansas, United States
Site recruitment: Not reported
L-MARC Research Center
Louisville, Kentucky, United States
Site recruitment: Not reported
Centennial Medical Group
Elkridge, Maryland, United States
Site recruitment: Not reported
MedStar Health Research Institute (MedStar Physician Based Research Network)
Hyattsville, Maryland, United States
Site recruitment: Not reported
ActivMed Practices and Research
Methuen, Massachusetts, United States
Site recruitment: Not reported
Arcturus Healthcare , PLC, Troy Internal Medicine Research Division
Troy, Michigan, United States
Site recruitment: Not reported
StudyMetrix Research
City of Saint Peters, Missouri, United States
Site recruitment: Not reported
Glacier View Research Institute - Endocrinology
Kalispell, Montana, United States
Site recruitment: Not reported
Weill Cornell Medical College
New York, New York, United States
Site recruitment: Not reported
University of North Carolina Medical Center
Chapel Hill, North Carolina, United States
Site recruitment: Not reported
PharmQuest
Greensboro, North Carolina, United States
Site recruitment: Not reported
Wake Forest University Baptist Medical Center (WFUBMC)
Winston-Salem, North Carolina, United States
Site recruitment: Not reported
Lillestol Research
Fargo, North Dakota, United States
Site recruitment: Not reported
Aventiv Research Inc
Columbus, Ohio, United States
Site recruitment: Not reported
Intend Research, LLC
Norman, Oklahoma, United States
Site recruitment: Not reported
Summit Research Network
Portland, Oregon, United States
Site recruitment: Not reported
Capital Area Research, LLC
Camp Hill, Pennsylvania, United States
Site recruitment: Not reported
Tribe Clinical Research, LLC
Greenville, South Carolina, United States
Site recruitment: Not reported
The University of Texas Health Science Center at Houston
Bellaire, Texas, United States
Site recruitment: Not reported
Dallas Diabetes Research Center
Dallas, Texas, United States
Site recruitment: Not reported
North Texas Endocrine Center
Dallas, Texas, United States
Site recruitment: Not reported
Biopharma Informatic, LLC
Houston, Texas, United States
Site recruitment: Not reported
North Hills Family Medicine/North Hills Medical Research
North Richland Hills, Texas, United States
Site recruitment: Not reported
Clinical Trials of Texas, Inc.
San Antonio, Texas, United States
Site recruitment: Not reported
Northwest Houston Heart Center
Tomball, Texas, United States
Site recruitment: Not reported
Health Research of Hampton Roads, Inc.
Newport News, Virginia, United States
Site recruitment: Not reported
Capital Clinical Research Center
Olympia, Washington, United States
Site recruitment: Not reported
Rainier Clinical Research Center
Renton, Washington, United States
Site recruitment: Not reported
CEDIC
CABA, Buenos Aires, Argentina
Site recruitment: Not reported
Centro Médico Viamonte
CABA, Buenos Aires, Argentina
Site recruitment: Not reported
Stat Research S.A.
Ciudad Autónoma de Buenos Aire, Buenos Aires, Argentina
Site recruitment: Not reported
Mautalen Salud e Investigación
Buenos Aires, Ciudad Autónoma de Buenos Aire, Argentina
Site recruitment: Not reported
Centro Medico Dr Laura Maffei Investigacion Clinica Aplicada
Ciudad Autonoma de Buenos Aire, Ciudad Autónoma de Buenos Aire, Argentina
Site recruitment: Not reported
Instituto Médico Catamarca IMEC
Rosario, Santa Fe Province, Argentina
Site recruitment: Not reported
Asociación de Beneficencia Hospital Sirio Libanés
Buenos Aires, Argentina
Site recruitment: Not reported
CEDOES
Vitória, Espírito Santo, Brazil
Site recruitment: Not reported
Cline Research Center
Curitiba, Paraná, Brazil
Site recruitment: Not reported
Núcleo de Pesquisa Clínica do Rio Grande do Sul
Porto Alegre, Rio Grande do Sul, Brazil
Site recruitment: Not reported
Centro de Pesquisa Sao Lucas
Campinas, São Paulo, Brazil
Site recruitment: Not reported
ISPEM - Instituto São José dos Campos em Pesquisas Médicas
São José dos Campos, São Paulo, Brazil
Site recruitment: Not reported
BR Trials - Ensaios Clinicos e Consultoria
São Paulo, São Paulo, Brazil
Site recruitment: Not reported
IBPClin - Instituto Brasil de Pesquisa Clínica
Rio de Janeiro, Brazil
Site recruitment: Not reported
CPQuali Pesquisa Clínica
São Paulo, Brazil
Site recruitment: Not reported
Centro de Endocrinologia Alcantara Gonzalez
Bayamón, Puerto Rico
Site recruitment: Not reported
Private Practice Dr. Martha Gomez Cuellar
San Juan, Puerto Rico
Site recruitment: Not reported
Wellness clinical Research Vega Baja
Vega Baja, Puerto Rico
Site recruitment: Not reported
Chung Shan Medical University Hospital
Taichung, Taiwan
Site recruitment: Not reported
China Medical University Hospital
Taichung, Taiwan
Site recruitment: Not reported
National Cheng-Kung Uni. Hosp.
Tainan, Taiwan
Site recruitment: Not reported
National Taiwan University Hospital
Taipei, Taiwan
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Explore the world’s study registries

These links open external registries; their records are not merged into the results above. WHO ICTRP provides a broader search across contributing registries. Search the same generic name, aliases and development codes in relevant regions. One multinational study may appear in more than one registry, so compare registration identifiers before counting it twice.

Worldwide

Africa

Pan African Clinical Trial Registry ↗

Americas

Asia

Middle East

Europe

Oceania

Australia / New Zealand — ANZCTR ↗

Registry directory checked October 5, 2026 against the WHO registry network. This is a starting point, not complete coverage of every country or continent. Record availability, language and update schedules vary by registry.

Worldwide Study Finder

Loading registry information…

Worldwide Study Finder

Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.

Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.

Find a study

Registry search results

Matching records; showing 20 on this page, newest registry updates first. Search checked 2026-10-08 03:12 UTC. Counts are registry matches, not unique peptides or a worldwide total.

Phase 3CompletedINTERVENTIONAL

Obstructive Sleep Apnea Master Protocol GPIF: A Study of Tirzepatide (LY3298176) in Participants With Obstructive Sleep Apnea

ClinicalTrials.gov · NCT05412004 · Registry updated: 2025-04-30

Condition / research focus: Obstructive Sleep Apnea; Obesity
Sponsor: Eli Lilly and Company
Countries with listed sites: Australia · Brazil · China · Czechia · Germany · Japan · Mexico · Puerto Rico · Taiwan · United States
Registry dates and results: Start: 2022-06-21. Completion: 2024-03-29 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Tirzepatide (drug) — also listed as: LY3298176
Placebo (drug)

Where the study takes place — 58 listed sites

Artemis Institute for Clinical Research
Riverside, California, United States
Site recruitment: Not reported
Teradan Clinical Trials, LLC
Brandon, Florida, United States
Site recruitment: Not reported
Renstar Medical Research
Ocala, Florida, United States
Site recruitment: Not reported
Palm Beach Research Center
West Palm Beach, Florida, United States
Site recruitment: Not reported
NeuroTrials Research Inc
Atlanta, Georgia, United States
Site recruitment: Not reported
Rocky Mountain Clinical Research
Idaho Falls, Idaho, United States
Site recruitment: Not reported
Brengle Family Medicine
Indianapolis, Indiana, United States
Site recruitment: Not reported
Lillestol Research
Fargo, North Dakota, United States
Site recruitment: Not reported
NeuroScience Research Center
Canton, Ohio, United States
Site recruitment: Not reported
CTI-CRC
Cincinnati, Ohio, United States
Site recruitment: Not reported
Office 18
Pittsburgh, Pennsylvania, United States
Site recruitment: Not reported
Preferred Primary Care Physicians
Uniontown, Pennsylvania, United States
Site recruitment: Not reported
FutureSearch Trials of Neurology
Austin, Texas, United States
Site recruitment: Not reported
Gadolin Research
Beaumont, Texas, United States
Site recruitment: Not reported
Advanced Neuro Research Center - ANRC
El Paso, Texas, United States
Site recruitment: Not reported
Epic Medical Research
Red Oak, Texas, United States
Site recruitment: Not reported
Sleep Therapy Research Center
San Antonio, Texas, United States
Site recruitment: Not reported
Rainier Clinical Research Center
Renton, Washington, United States
Site recruitment: Not reported
Woolcock Institute of Medical Research
Sydney, New South Wales, Australia
Site recruitment: Not reported
Flinders University
Bedford Park, South Australia, Australia
Site recruitment: Not reported
Núcleo de Pesquisa Clínica do Rio Grande do Sul
Porto Alegre, Rio Grande do Sul, Brazil
Site recruitment: Not reported
CPCLIN
São Paulo, São Paulo, Brazil
Site recruitment: Not reported
CPQuali Pesquisa Clínica
São Paulo, Brazil
Site recruitment: Not reported
Hospital das Clinicas FMUSP
São Paulo, Brazil
Site recruitment: Not reported
BR Trials - Ensaios Clinicos e Consultoria
São Paulo, Brazil
Site recruitment: Not reported
Hospital das Clinicas FMUSP
São Paulo, Brazil
Site recruitment: Not reported
The Second Affiliated Hospital of Nanjing Medical University
Nanjing, Jiangsu, China
Site recruitment: Not reported
Wuxi People's Hospital
Wuxi, Jiangsu, China
Site recruitment: Not reported
The First Hospital of Jilin University
Changchun, Jilin, China
Site recruitment: Not reported
Zhongshan Hospital,Fudan University
Shanghai, Shanghai Municipality, China
Site recruitment: Not reported
West China Hospital, Sichuan University
Chengdu, Sichuan, China
Site recruitment: Not reported
Tianjin Medical University General Hospital
Tianjin, Tianjin Municipality, China
Site recruitment: Not reported
Vseobecna fakultni nemocnice v Praze
Prague, Czechia
Site recruitment: Not reported
Praglandia s.r.o
Prague, Czechia
Site recruitment: Not reported
Siteworks GmbH
Hanover, Lower Saxony, Germany
Site recruitment: Not reported
InnoDiab Forschung Gmbh
Essen, North Rhine-Westphalia, Germany
Site recruitment: Not reported
Institut für Diabetesforschung GmbH Münster
Münster, North Rhine-Westphalia, Germany
Site recruitment: Not reported
RED-Institut GmbH
Oldenburg in Holstein, Schleswig-Holstein, Germany
Site recruitment: Not reported
Lungenpraxis Schleswig
Schleswig, Schleswig-Holstein, Germany
Site recruitment: Not reported
Advanced Sleep Research
Berlin, Germany
Site recruitment: Not reported
Diabeteszentrum Hamburg West
Hamburg, Germany
Site recruitment: Not reported
Koujunkai Daido Clinic
Nagoya, Aichi-ken, Japan
Site recruitment: Not reported
Kirigaokatsuda Hospital
Kitakyushu, Fukuoka, Japan
Site recruitment: Not reported
RESM Respiratory and Sleep Medical Care Clinic
Yokohama, Kanagawa, Japan
Site recruitment: Not reported
Sakai City Medical Center
Sakai, Osaka, Japan
Site recruitment: Not reported
Fukuwa Clinic
Chuo-ku, Tokyo, Japan
Site recruitment: Not reported
Osaka Kaisei Hospital
Osaka, Japan
Site recruitment: Not reported
Private Practice - Dr. Arechavaleta Granell Maria del Rosario
Guadalajara, Jalisco, Mexico
Site recruitment: Not reported
Unidad de Investigación Clínica y Atención Médica HEPA
Guadalajara, Jalisco, Mexico
Site recruitment: Not reported
RM Pharma Specialists
Mexico City, Mexico City, Mexico
Site recruitment: Not reported
Centro Especializado En Diabetes, Obesidad Y Prevencion De Enfermedades Cardiovasculares
Mexico City, Mexico City, Mexico
Site recruitment: Not reported
Servicios Integrales Nova de Monterrey S.A. de C.V.
San Nicolás de los Garza, Nuevo León, Mexico
Site recruitment: Not reported
Unidad Médica para la Salud Integral
San Nicolás de los Garza, Nuevo León, Mexico
Site recruitment: Not reported
Investigacion En Salud Y Metabolismo Sc
Chihuahua City, Mexico
Site recruitment: Not reported
Arké SMO S.A de C.V
Veracruz, Mexico
Site recruitment: Not reported
Puerto Rico Medical Research Center
Hato Rey, Puerto Rico, Puerto Rico
Site recruitment: Not reported
China Medical University Hospital
Taichung, Taiwan
Site recruitment: Not reported
National Cheng Kung University Hospital
Tainan, Taiwan
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4RecruitingINTERVENTIONAL

Subcutaneous Tirzepatide Once-weekly in Patients With Obesity and Knee Osteoarthritis (STOP KNEE-OA)

ClinicalTrials.gov · NCT06191848 · Registry updated: 2025-04-30

Condition / research focus: Obesity; Knee Osteoarthritis; Osteoarthritis, Knee
Sponsor: University of Melbourne
Countries with listed sites: Australia
Registry dates and results: Start: 2024-11-19. Completion: 2037-05 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Tirzepatide (drug)
Placebo (drug)

Where the study takes place — 4 listed sites

St Vincents Hospital Melbourne
Fitzroy, Victoria, Australia
Site recruitment: Recruiting
Western Health
Melbourne, Victoria, Australia
Site recruitment: Recruiting
Austin Health-Repatriation Hospital
Melbourne, Victoria, Australia
Site recruitment: Recruiting
Eastern Health
Melbourne, Victoria, Australia
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 1CompletedINTERVENTIONAL

A Study of Tirzepatide (LY3298176) in Healthy Lactating Females

ClinicalTrials.gov · NCT05978713 · Registry updated: 2025-04-27

Condition / research focus: Healthy
Sponsor: Eli Lilly and Company
Countries with listed sites: United States
Registry dates and results: Start: 2023-07-31. Completion: 2024-03-12 (may be estimated). Results are posted in this registry.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Tirzepatide (drug) — also listed as: LY3298176

Where the study takes place — 1 listed sites

Las Vegas Clinical Research Unit - PPD
Las Vegas, Nevada, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3Active, not recruitingINTERVENTIONAL

Efficacy and Safety of Tirzepatide for Weight Management

ClinicalTrials.gov · NCT06918405 · Registry updated: 2025-04-09

Condition / research focus: Obesity and Obesity-related Medical Conditions
Sponsor: Chittagong Medical College
Countries with listed sites: Bangladesh
Registry dates and results: Start: 2025-01-01. Completion: 2026-06-30 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Tirzepatide (drug)

Where the study takes place — 1 listed sites

Chittagong Medical College Hospital
Chittagong, Bangladesh
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableRecruitingINTERVENTIONAL

MAINTAIN (Mucosal AblatIoN Therapy After INcretins)

ClinicalTrials.gov · NCT06734312 · Registry updated: 2025-03-21

Condition / research focus: Obesity and Obesity-related Medical Conditions; Obesity and Overweight; Obesity Prevention; Obesity Recidivism; GLP-1; Ablation Techniques
Sponsor: Dr. Christopher McGowan
Countries with listed sites: United States
Registry dates and results: Start: 2025-01-01. Completion: 2026-06 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Gastric Fundal Mucosal Ablation (GFMA) (device)

Where the study takes place — 2 listed sites

True You Weight Loss
Cary, North Carolina, United States
Site recruitment: Not yet recruiting
True You Weight Loss
Cary, North Carolina, United States
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 2TerminatedINTERVENTIONAL

Efficacy and Safety of Oral Azelaprag Plus Once Weekly Tirzepatide Compared with Tirzepatide Alone in Participants with Obesity Aged 55 Years and Over

ClinicalTrials.gov · NCT06515418 · Registry updated: 2025-03-13

Condition / research focus: Obesity
Sponsor: BioAge Labs, Inc.
Countries with listed sites: United States
Registry dates and results: Start: 2024-06-27. Completion: 2025-02-12 (may be estimated). No results posted in this registry response.

Products and interventions (4)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oral Azelaprag (BGE-105) (drug) — also listed as: BGE-105
Oral Placebo for Azelaprag (BGE-105) (drug) — also listed as: Placebo
Tirzepatide (drug)
Tirzepatide Placebo (drug)

Where the study takes place — 14 listed sites

Site 110
Mesa, Arizona, United States
Site recruitment: Not reported
Site 107
Los Angeles, California, United States
Site recruitment: Not reported
Site 103
Montclair, California, United States
Site recruitment: Not reported
Site 105
Spring Valley, California, United States
Site recruitment: Not reported
Site 100
Louisville, Kentucky, United States
Site recruitment: Not reported
Site 101
Marrero, Louisiana, United States
Site recruitment: Not reported
Site 112
Boston, Massachusetts, United States
Site recruitment: Not reported
Site 111
Troy, Michigan, United States
Site recruitment: Not reported
Site 113
City of Saint Peters, Missouri, United States
Site recruitment: Not reported
Site 106
Butte, Montana, United States
Site recruitment: Not reported
Site 109
Fargo, North Dakota, United States
Site recruitment: Not reported
Site 108
Beachwood, Ohio, United States
Site recruitment: Not reported
Site 102
Dallas, Texas, United States
Site recruitment: Not reported
Site 104
St. George, Utah, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2Active, not recruitingINTERVENTIONAL

A Phase 2 Study Evaluating the Co-Administration of Bremelanotide With Tirzepatide for the Treatment of Obesity

ClinicalTrials.gov · NCT06565611 · Registry updated: 2025-03-06

Condition / research focus: Obesity
Sponsor: Palatin Technologies, Inc
Countries with listed sites: United States
Registry dates and results: Start: 2024-08-05. Completion: 2025-03-31 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

bremelanotide (drug)
tirzepatide (drug)

Where the study takes place — 4 listed sites

University Clinical Research-DeLand LLC, d/b/a Accel Research
DeLand, Florida, United States
Site recruitment: Not reported
Lynn Health Science Institute
Oklahoma City, Oklahoma, United States
Site recruitment: Not reported
Coastal Carolina Research Center
North Charleston, South Carolina, United States
Site recruitment: Not reported
Lynn Institute of Chattanooga
Chattanooga, Tennessee, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableNot yet recruitingOBSERVATIONAL

Impact of Antiobesity Medications on Appetite and Appetite-related Hormones and Metabolites.

ClinicalTrials.gov · NCT06856928 · Registry updated: 2025-03-04

Condition / research focus: Obesity; Drug
Sponsor: University of Colorado, Denver
Countries with listed sites: No country reported
Registry dates and results: Start: 2025-03. Completion: 2027-12 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Meal Challenge (other)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase 4WithdrawnINTERVENTIONAL

Effects of Tirzepatide Plus Intensive Lifestyle Therapy on Body Weight and Metabolic Health in Latinos With Obesity

ClinicalTrials.gov · NCT06009653 · Registry updated: 2025-02-25

Condition / research focus: Obesity; Metabolic Disease
Sponsor: Washington University School of Medicine
Countries with listed sites: United States
Registry dates and results: Start: 2023-09-13. Completion: 2024-05-29 (may be estimated). No results posted in this registry response.

Products and interventions (4)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Standard Care (behavioral)
Culturally-tailored dietary and behavioral intensive lifestyle intervention (behavioral)
Placebo (drug)
Tirzepatide (drug)

Where the study takes place — 1 listed sites

Sansum Diabetes Research Institute
Santa Barbara, California, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2CompletedINTERVENTIONAL

Study That Tests AD109 in Patients Taking GLP-1 Drugs

ClinicalTrials.gov · NCT06400615 · Registry updated: 2025-02-19

Condition / research focus: OSA
Sponsor: Apnimed
Countries with listed sites: United States
Registry dates and results: Start: 2024-05-20. Completion: 2024-12-26 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

AD109 (drug)

Where the study takes place — 4 listed sites

Pinnacle Research Group, LLC
Anniston, Alabama, United States
Site recruitment: Not reported
Clinical Neuroscience Solutions, Inc
Jacksonville, Florida, United States
Site recruitment: Not reported
Monroe Biomedical Research
Monroe, North Carolina, United States
Site recruitment: Not reported
Clinical Neuroscience Solutions, Inc
Memphis, Tennessee, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4WithdrawnINTERVENTIONAL

Gastric Sleeve-Induced Weight Loss on Shortness of Breath in Obesity

ClinicalTrials.gov · NCT05812183 · Registry updated: 2025-02-14

Condition / research focus: Dyspnea; Quality of Life
Sponsor: University of California, Los Angeles
Countries with listed sites: No country reported
Registry dates and results: Start: 2023-07-09. Completion: 2025-02-12 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Bariatric surgery (device)
Medical weight loss (drug)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase 2CompletedINTERVENTIONAL

A Study of Tirzepatide (LY3298176) in Participants With Nonalcoholic Steatohepatitis (NASH)

ClinicalTrials.gov · NCT04166773 · Registry updated: 2025-01-24

Condition / research focus: Nonalcoholic Steatohepatitis
Sponsor: Eli Lilly and Company
Countries with listed sites: Belgium · France · Israel · Italy · Japan · Mexico · Poland · Spain · United Kingdom · United States
Registry dates and results: Start: 2019-11-19. Completion: 2024-01-10 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Tirzepatide (drug) — also listed as: LY3298176
Placebo (drug)

Where the study takes place — 112 listed sites

University of Alabama-The Kirklin Clinic
Birmingham, Alabama, United States
Site recruitment: Not reported
Synexus Clinical Research US, Inc.
Chandler, Arizona, United States
Site recruitment: Not reported
Fresno Clinical Research Center
Fresno, California, United States
Site recruitment: Not reported
National Research Institute - Huntington Park
Huntington Park, California, United States
Site recruitment: Not reported
UCSD - Altman Clinical and Translational Research Institute (ACTRI)
La Jolla, California, United States
Site recruitment: Not reported
National Research Institute - Wilshire
Los Angeles, California, United States
Site recruitment: Not reported
Catalina Research Institute, LLC
Montclair, California, United States
Site recruitment: Not reported
Diabetes Medical Center of California
Northridge, California, United States
Site recruitment: Not reported
Velocity Clinical Research, Panorama City
Panorama City, California, United States
Site recruitment: Not reported
Inland Empire Clinical Trials, LLC
Rialto, California, United States
Site recruitment: Not reported
Velocity Clinical Research, Santa Ana
Santa Ana, California, United States
Site recruitment: Not reported
Excel Medical Clinical Trials
Boca Raton, Florida, United States
Site recruitment: Not reported
Alliance for Multispecialty Research, LLC
Coral Gables, Florida, United States
Site recruitment: Not reported
Research Centers of America ( Hollywood )
Hollywood, Florida, United States
Site recruitment: Not reported
East Coast Institute for Research, LLC
Jacksonville, Florida, United States
Site recruitment: Not reported
IHS Health Research
Kissimmee, Florida, United States
Site recruitment: Not reported
Accel Research Sites - Maitland Clinical Research Unit
Maitland, Florida, United States
Site recruitment: Not reported
Clinical Pharmacology of Miami
Miami, Florida, United States
Site recruitment: Not reported
The Center for Digestive Health
Orlando, Florida, United States
Site recruitment: Not reported
Synexus Clinical Research US, Inc.
Orlando, Florida, United States
Site recruitment: Not reported
Synexus Clinical Research US, Inc.
The Villages, Florida, United States
Site recruitment: Not reported
Synexus Clinical Research
Chicago, Illinois, United States
Site recruitment: Not reported
Indiana University Health Hospital
Indianapolis, Indiana, United States
Site recruitment: Not reported
Iowa Diabetes and Endocrinology Research Center
West Des Moines, Iowa, United States
Site recruitment: Not reported
Cotton O'Neil Clinical Research Center
Topeka, Kansas, United States
Site recruitment: Not reported
Alliance for Multispecialty Research, LLC
Wichita, Kansas, United States
Site recruitment: Not reported
Tandem Clinical Research
Marrero, Louisiana, United States
Site recruitment: Not reported
The National Diabetes & Obesity Research Institute
Biloxi, Mississippi, United States
Site recruitment: Not reported
Southern Therapy and Advanced Research (STAR) LLC
Jackson, Mississippi, United States
Site recruitment: Not reported
Buffalo Clinical and Translational Research Center
Buffalo, New York, United States
Site recruitment: Not reported
NYU Langone Health
New York, New York, United States
Site recruitment: Not reported
Icahn School of Medicine at Mount Sinai
New York, New York, United States
Site recruitment: Not reported
Montefiore Medical Center
The Bronx, New York, United States
Site recruitment: Not reported
Diabetes & Endocrinology Consultants, PC
Morehead City, North Carolina, United States
Site recruitment: Not reported
Geisinger Medical Center
Danville, Pennsylvania, United States
Site recruitment: Not reported
WR-Clinsearch, LLC
Chattanooga, Tennessee, United States
Site recruitment: Not reported
Dallas Diabetes Research Center
Dallas, Texas, United States
Site recruitment: Not reported
Radiant Research - Dallas North
Dallas, Texas, United States
Site recruitment: Not reported
Liver Center of Texas, PLLC
Dallas, Texas, United States
Site recruitment: Not reported
Texoma Medical Center
Denison, Texas, United States
Site recruitment: Not reported
Texas Diabetes & Endocrinology, P.A.
Round Rock, Texas, United States
Site recruitment: Not reported
American Research Corporation at Texas Liver Institute
San Antonio, Texas, United States
Site recruitment: Not reported
Synexus Clinical Research US, Inc.
San Antonio, Texas, United States
Site recruitment: Not reported
Endeavor Clinical Trials
San Antonio, Texas, United States
Site recruitment: Not reported
National Clinical Research, Inc
Richmond, Virginia, United States
Site recruitment: Not reported
Virginia Commonwealth University (VCU) Medical Center
Richmond, Virginia, United States
Site recruitment: Not reported
Harborview Medical Center/University of Washington
Seattle, Washington, United States
Site recruitment: Not reported
Antwerp University Hospital
Edegem, Antwerpen, Belgium
Site recruitment: Not reported
UZ Brussel
Brussels, Bruxelles-Capitale, Région de, Belgium
Site recruitment: Not reported
UZ Gent
Ghent, Oost-Vlaanderen, Belgium
Site recruitment: Not reported
UZ Leuven
Leuven, Vlaams-Brabant, Belgium
Site recruitment: Not reported
AZ Delta vzw
Roeselare, West-Vlaanderen, Belgium
Site recruitment: Not reported
CHU Bordeaux Haut-Leveque
Pessac, Aquitaine, France
Site recruitment: Not reported
Groupe Hospitalier Mutualiste Les Portes du Sud
Vénissieux, Auvergne-Rhône-Alpes, France
Site recruitment: Not reported
Centre Hospitalier Universitaire de Limoges - Hôpital Dupuytren
Limoges, Haute-Vienne, France
Site recruitment: Not reported
Centre Hospitalier Universitaire d'Angers
Angers, Maine-et-Loire, France
Site recruitment: Not reported
Centre Hospitalier Lyon Sud
Pierre-Bénite, Rhône, France
Site recruitment: Not reported
Pitie Salpetriere University Hospital
Paris, France
Site recruitment: Not reported
Hôpital Saint Antoine
Paris, France
Site recruitment: Not reported
Sheba Medical Center
Ramat Gan, Central District, Israel
Site recruitment: Not reported
Hadassah Medical Center
Jerusalem, Jerusalem, Israel
Site recruitment: Not reported
Shaare Zedek Medical Center
Jerusalem, Jerusalem, Israel
Site recruitment: Not reported
Rambam Health Care Campus
Haifa, Northern District, Israel
Site recruitment: Not reported
Galilee Medical Center
Nahariya, Northern District, Israel
Site recruitment: Not reported
Carmel Hospital
Haifa, Israel
Site recruitment: Not reported
A.O.U. Policlinico Paolo Giaccone
Palermo, Sicily, Italy
Site recruitment: Not reported
Azienda Ospedaliero Universitaria Ospedali Riuniti Di Foggia
Foggia, Italy
Site recruitment: Not reported
Ospedale Santa Maria Goretti
Latina, Italy
Site recruitment: Not reported
Fondazione Policlinico Universitario Agostino Gemelli
Roma, Italy
Site recruitment: Not reported
Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino
Torino, Italy
Site recruitment: Not reported
Aichi Medical University Hospital
Nagakute-shi, Aichi-ken, Japan
Site recruitment: Not reported
JCHO Hokkaido Hospital
Sapporo, Hokkaido, Japan
Site recruitment: Not reported
Yokohama City University Hospital
Yokohama, Kanagawa, Japan
Site recruitment: Not reported
National Hospital Organization Yokohama Medical Center
Yokohama, Kanagawa, Japan
Site recruitment: Not reported
JADECOM Nara City Hospital
Nara, Nara, Japan
Site recruitment: Not reported
Hirakata kohsai Hospital
Higashi-cho, Hirakata-city, Osaka, Japan
Site recruitment: Not reported
Osaka Saiseikai Suita hospital
Suita, Osaka, Japan
Site recruitment: Not reported
Shimane University Hospital
Izumo, Shimane, Japan
Site recruitment: Not reported
Tokyo Medical And Dental University Medical Hospital
Bunkyō, Tokyo, Japan
Site recruitment: Not reported
Fukuiken Saiseikai Hospital
Fukui, Japan
Site recruitment: Not reported
Gifu Municipal Hospital
Gifu, Japan
Site recruitment: Not reported
Kumamoto Shinto General Hospital
Kumamoto, Japan
Site recruitment: Not reported
University Hospital,Kyoto Prefectural University of Medicine
Kyoto, Japan
Site recruitment: Not reported
Niigata University Medical & Dental Hospital
Niigata, Japan
Site recruitment: Not reported
Saga University Hospital
Saga, Japan
Site recruitment: Not reported
Yamagata University Hospital
Yamagata, Japan
Site recruitment: Not reported
Phylasis Clinicas Research
Cuautitlan Izcalli, Mexico City, Mexico
Site recruitment: Not reported
Grupo Medico Camino Sc
Mexico City, Mexico City, Mexico
Site recruitment: Not reported
Christus Muguerza Hospital Sur
Monterrey, Nuevo León, Mexico
Site recruitment: Not reported
Centro de Investigación y Gastroenterología
Cuauhtémoc, Mexico
Site recruitment: Not reported
Synexus Polska Sp. z o.o. Oddzial w Warszawie
Warsaw, Masovian Voivodeship, Poland
Site recruitment: Not reported
Synexus Polska Oddział w Lodzi
Lodz, Łódź Voivodeship, Poland
Site recruitment: Not reported
Clínica Juaneda
Palma de Mallorca, Balears [Baleares], Spain
Site recruitment: Not reported
Hospital Universitario Marqués de Valdecilla
Santander, Cantabria, Spain
Site recruitment: Not reported
Hospital Universitario Ramón y Cajal
Madrid, Madrid, Comunidad de, Spain
Site recruitment: Not reported
Instituto de Ciencias Médicas
Alicante, Spain
Site recruitment: Not reported
Hospital Universitario Puerta de Hierro Majadahonda
Madrid, Spain
Site recruitment: Not reported
Clínica nuevas Tecnologías en Diabetes y Endocrinología (NTDE)
Seville, Spain
Site recruitment: Not reported
Hospital Universitario Virgen Del Rocio
Seville, Spain
Site recruitment: Not reported
Queen Elizabeth Hospital Birmingham
Birmingham, England, United Kingdom
Site recruitment: Not reported
Synexus North East Clinical Research Centre
Hexham, England, United Kingdom
Site recruitment: Not reported
Royal London Hospital
London, England, United Kingdom
Site recruitment: Not reported
St. George's Hospital
London, England, United Kingdom
Site recruitment: Not reported
Synexus Clinical Research Centre - Lancashire
Chorley, Lancashire, United Kingdom
Site recruitment: Not reported
King's College Hospital
London, London, City of, United Kingdom
Site recruitment: Not reported
Queen's Medical Centre, Nottingham University Hospitals
Nottingham, Nottinghamshire, United Kingdom
Site recruitment: Not reported
John Radcliffe Hospital
Headington, Oxford, United Kingdom
Site recruitment: Not reported
Synexus North Teesside Clinical Research Centre
Stockton-on-Tees, Stockton-on-Tees, United Kingdom
Site recruitment: Not reported
Imperial College London - St Mary's Hospital
London, Westminster, United Kingdom
Site recruitment: Not reported
Synexus Midlands Clinical Research Centre
Birmingham, United Kingdom
Site recruitment: Not reported
Aintree University Hospital NHS Foundation Trust
Liverpool, United Kingdom
Site recruitment: Not reported
Synexus Manchester Clinical Research Centre
Manchester, United Kingdom
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

A Study to Determine the Feasibility of Online Recruitment of People Using an Anti-Obesity Medication for Weight Loss

ClinicalTrials.gov · NCT06761703 · Registry updated: 2025-01-14

Condition / research focus: Obesity
Sponsor: Amgen
Countries with listed sites: United States
Registry dates and results: Start: 2024-11-14. Completion: 2025-01-06 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

TAP® Micro Select Device (Touch Activated Phlebotomy) (device)

Where the study takes place — 1 listed sites

YourBio Health/CRT
Medford, Massachusetts, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

A Study of Tirzepatide (LY3298176) in Adults With Type 2 Diabetes Switching From a GLP-1 RA (SURPASS-SWITCH-2)

ClinicalTrials.gov · NCT05706506 · Registry updated: 2024-12-13

Condition / research focus: Type 2 Diabetes; Diabetes Mellitus, Type 2
Sponsor: Eli Lilly and Company
Countries with listed sites: United States
Registry dates and results: Start: 2023-03-08. Completion: 2023-10-31 (may be estimated). Results are posted in this registry.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Tirzepatide (drug) — also listed as: LY3298176

Where the study takes place — 32 listed sites

Fiel Family and Sports Medicine PC
Tempe, Arizona, United States
Site recruitment: Not reported
New Hope Research Development
Corona, California, United States
Site recruitment: Not reported
Velocity Clinical Research, Gardena
Gardena, California, United States
Site recruitment: Not reported
Velocity Clinical Research, Huntington Park
Huntington Park, California, United States
Site recruitment: Not reported
Velocity Clinical Research, Huntington Park
Los Angeles, California, United States
Site recruitment: Not reported
Valley Clinical Trials, Inc.
Northridge, California, United States
Site recruitment: Not reported
Dream Team Clinical Research
Pomona, California, United States
Site recruitment: Not reported
Scripps Whittier Diabetes Institute
San Diego, California, United States
Site recruitment: Not reported
Metabolic Institute of America
Tarzana, California, United States
Site recruitment: Not reported
CMR of Greater New Haven, LLC
Waterbury, Connecticut, United States
Site recruitment: Not reported
Velocity Clinical Research, Hallandale Beach
Hallandale, Florida, United States
Site recruitment: Not reported
East Coast Institute for Research, LLC
Jacksonville, Florida, United States
Site recruitment: Not reported
Florida Institute For Clinical Research, LLC
Orlando, Florida, United States
Site recruitment: Not reported
New Tampa Health
Tampa, Florida, United States
Site recruitment: Not reported
Georgia Clinical Research
Lawrenceville, Georgia, United States
Site recruitment: Not reported
Endocrine Research Solutions, Inc.
Roswell, Georgia, United States
Site recruitment: Not reported
Velocity Clinical Research, Valparaiso
Valparaiso, Indiana, United States
Site recruitment: Not reported
Iowa Diabetes and Endocrinology Research Center
West Des Moines, Iowa, United States
Site recruitment: Not reported
Cotton O'Neil Clinic
Topeka, Kansas, United States
Site recruitment: Not reported
Versailles Family Medicine
Versailles, Kentucky, United States
Site recruitment: Not reported
Endocrine and Metabolic Consultants
Rockville, Maryland, United States
Site recruitment: Not reported
Clinical Research Professionals
Chesterfield, Missouri, United States
Site recruitment: Not reported
Clinical Research of South Nevada
Las Vegas, Nevada, United States
Site recruitment: Not reported
Palm Research Center Tenaya
Las Vegas, Nevada, United States
Site recruitment: Not reported
Advanced Medical Research
Maumee, Ohio, United States
Site recruitment: Not reported
Conrad Clinical Research
Edmond, Oklahoma, United States
Site recruitment: Not reported
Mountain View Clinical Research, Inc.
Greenville, South Carolina, United States
Site recruitment: Not reported
Texas Diabetes & Endocrinology, P.A.
Austin, Texas, United States
Site recruitment: Not reported
North Texas Endocrine Center
Dallas, Texas, United States
Site recruitment: Not reported
Memorial City Endocrine Consultants
Houston, Texas, United States
Site recruitment: Not reported
Consano Clinical Research, LLC
Shavano Park, Texas, United States
Site recruitment: Not reported
ClinPoint Trials
Waxahachie, Texas, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2RecruitingINTERVENTIONAL

Tirzepatide: Reversal of Lipotoxicity and Adipose Tissue Dysfunction in Humans With Overweight/Obesity

ClinicalTrials.gov · NCT05912621 · Registry updated: 2024-12-04

Condition / research focus: Obesity; Overweight and Obesity; Overweight
Sponsor: Stanford University
Countries with listed sites: United States
Registry dates and results: Start: 2023-11-09. Completion: 2029-12 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Tirzepatide (drug) — also listed as: Mounjaro

Where the study takes place — 1 listed sites

Clinical and Translational Research Unit
Palo Alto, California, United States
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 4RecruitingINTERVENTIONAL

Effect of Tirzepatide on Progression of Coronary Atherosclerosis Using MDCT

ClinicalTrials.gov · NCT05708859 · Registry updated: 2024-10-15

Condition / research focus: Type II Diabetes; Atherosclerosis
Sponsor: Matthew J. Budoff
Countries with listed sites: United States
Registry dates and results: Start: 2024-01-02. Completion: 2026-05 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Tirzepatide (drug) — also listed as: Mounjaro
Placebo (drug)

Where the study takes place — 1 listed sites

Lundquist Institute for Biomedical Innovation at Harbor UCLA Medical Center (The Lundquist Institute)
Torrance, California, United States
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 1CompletedINTERVENTIONAL

A Research Study Looking at Similarity Between Tirzepatide Versions for Different Injection Devices

ClinicalTrials.gov · NCT05810597 · Registry updated: 2024-10-15

Condition / research focus: Healthy
Sponsor: Eli Lilly and Company
Countries with listed sites: United States
Registry dates and results: Start: 2023-04-03. Completion: 2023-07-17 (may be estimated). Results are posted in this registry.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Tirzepatide (drug) — also listed as: LY3298176
Single Dose Pen (device)
Multi-use Prefilled Pen (device)

Where the study takes place — 3 listed sites

Qps-Mra, Llc
South Miami, Florida, United States
Site recruitment: Not reported
ICON Early Phase Services
San Antonio, Texas, United States
Site recruitment: Not reported
ICON
Salt Lake City, Utah, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

A Study of Tirzepatide (LY3298176) in Participants With Obesity Disease

ClinicalTrials.gov · NCT04844918 · Registry updated: 2024-07-16

Condition / research focus: Obesity
Sponsor: Eli Lilly and Company
Countries with listed sites: Japan
Registry dates and results: Start: 2021-05-10. Completion: 2023-06-24 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Tirzepatide (drug) — also listed as: LY3298176
Placebo (other)

Where the study takes place — 18 listed sites

Kohnodai Hospital, National Center for Global Health and Medicine
Ichikawa, Chiba, Japan
Site recruitment: Not reported
Saiseikai Matsuyama Hospital
Matsuyama, Ehime, Japan
Site recruitment: Not reported
Takai Internal Medicine Clinic
Kamakura-shi, Kanagawa, Japan
Site recruitment: Not reported
Saiseikai Yokohamashi Tobu Hospital
Yokohama, Kanagawa, Japan
Site recruitment: Not reported
Motomachi Takatsuka Naika Clinic
Yokohama, Kanagawa, Japan
Site recruitment: Not reported
Osaka Saiseikai Suita hospital
Suita, Osaka, Japan
Site recruitment: Not reported
Medical Corporation Heishinkai OCROM Clinic
Suita-shi, Osaka, Japan
Site recruitment: Not reported
Takatsuki Red Cross Hospital
Takatsuki, Osaka, Japan
Site recruitment: Not reported
The Institute for Adult Disease, Asahi Life Foundation
Chuo-ku, Tokyo, Japan
Site recruitment: Not reported
Tokyo-Eki Center-building Clinic
Chuo-ku, Tokyo, Japan
Site recruitment: Not reported
Medical Corporation Chiseikai Tokyo Center Clinic
Chuo-ku, Tokyo, Japan
Site recruitment: Not reported
Fukuwa Clinic
Chuo-ku, Tokyo, Japan
Site recruitment: Not reported
Saiseikai Central Hospital
Minato-Ku, Tokyo, Japan
Site recruitment: Not reported
Shimokitazawa Tomo Clinic
Setagaya-ku, Tokyo, Japan
Site recruitment: Not reported
Miho Clinic
Shinagawa-ku, Tokyo, Japan
Site recruitment: Not reported
Medical Corporation Heishinkai ToCROM Clinic
Shinjuku-ku, Tokyo, Japan
Site recruitment: Not reported
Yamagata Tokushukai Hospital
Yamagata, Yamagata, Japan
Site recruitment: Not reported
AMC Nishiumeda Clinic
Osaka, Japan
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Role Of Metabolic Adaptation In Weight Regain

ClinicalTrials.gov · NCT05766358 · Registry updated: 2024-06-10

Condition / research focus: Weight Loss; Weight Gain; Obesity
Sponsor: Pennington Biomedical Research Center
Countries with listed sites: United States
Registry dates and results: Start: 2022-10-06. Completion: 2024-05-24 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Intensive lifestyle change therapy (behavioral)
Tirzepatide (drug)

Where the study takes place — 1 listed sites

Pennington Biomedical Research Center
Baton Rouge, Louisiana, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight for the Maintenance of Weight Loss

ClinicalTrials.gov · NCT04660643 · Registry updated: 2024-05-22

Condition / research focus: Obesity; Overweight
Sponsor: Eli Lilly and Company
Countries with listed sites: Argentina · Brazil · Puerto Rico · Taiwan · United States
Registry dates and results: Start: 2021-03-29. Completion: 2023-05-18 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Tirzepatide (drug) — also listed as: LY3298176
Placebo (other)

Where the study takes place — 70 listed sites

Cahaba Research
Pelham, Alabama, United States
Site recruitment: Not reported
Scripps Memorial Hospital La Jolla
La Jolla, California, United States
Site recruitment: Not reported
National Research Institute - Wilshire
Los Angeles, California, United States
Site recruitment: Not reported
National Research Institute
Panorama City, California, United States
Site recruitment: Not reported
Artemis Institute for Clinical Research
San Diego, California, United States
Site recruitment: Not reported
University Clinical Investigators, Inc.
Tustin, California, United States
Site recruitment: Not reported
New West Physicians Clinical Research
Golden, Colorado, United States
Site recruitment: Not reported
Optumcare Colorado Springs - Monument
Monument, Colorado, United States
Site recruitment: Not reported
Care Partners Clinical Research
Jacksonville, Florida, United States
Site recruitment: Not reported
South Florida Clinical Research Institute
Margate, Florida, United States
Site recruitment: Not reported
Renstar Medical Research
Ocala, Florida, United States
Site recruitment: Not reported
ForCare Clinical Research
Tampa, Florida, United States
Site recruitment: Not reported
Endocrine Research Solutions, Inc.
Roswell, Georgia, United States
Site recruitment: Not reported
SKY Clinical Research Network Group-Blake
Union City, Georgia, United States
Site recruitment: Not reported
East-West Medical Research Institute
Honolulu, Hawaii, United States
Site recruitment: Not reported
Rocky Mountain Clinical Research
Idaho Falls, Idaho, United States
Site recruitment: Not reported
Healthcare Research Network - Chicago
Flossmoor, Illinois, United States
Site recruitment: Not reported
Clinical Investigation Specialists
Gurnee, Illinois, United States
Site recruitment: Not reported
Midwest Institute For Clinical Research
Indianapolis, Indiana, United States
Site recruitment: Not reported
American Health Network of Indiana, LLC - New Albany
New Albany, Indiana, United States
Site recruitment: Not reported
Cotton O'Neil Clinic
Topeka, Kansas, United States
Site recruitment: Not reported
L-MARC Research Center
Louisville, Kentucky, United States
Site recruitment: Not reported
Centennial Medical Group
Elkridge, Maryland, United States
Site recruitment: Not reported
MedStar Health Research Institute (MedStar Physician Based Research Network)
Hyattsville, Maryland, United States
Site recruitment: Not reported
ActivMed Practices and Research
Methuen, Massachusetts, United States
Site recruitment: Not reported
Arcturus Healthcare , PLC, Troy Internal Medicine Research Division
Troy, Michigan, United States
Site recruitment: Not reported
StudyMetrix Research
City of Saint Peters, Missouri, United States
Site recruitment: Not reported
Glacier View Research Institute - Endocrinology
Kalispell, Montana, United States
Site recruitment: Not reported
Weill Cornell Medical College
New York, New York, United States
Site recruitment: Not reported
University of North Carolina Medical Center
Chapel Hill, North Carolina, United States
Site recruitment: Not reported
PharmQuest
Greensboro, North Carolina, United States
Site recruitment: Not reported
Wake Forest University Baptist Medical Center (WFUBMC)
Winston-Salem, North Carolina, United States
Site recruitment: Not reported
Lillestol Research
Fargo, North Dakota, United States
Site recruitment: Not reported
Aventiv Research Inc
Columbus, Ohio, United States
Site recruitment: Not reported
Intend Research, LLC
Norman, Oklahoma, United States
Site recruitment: Not reported
Summit Research Network
Portland, Oregon, United States
Site recruitment: Not reported
Capital Area Research, LLC
Camp Hill, Pennsylvania, United States
Site recruitment: Not reported
Tribe Clinical Research, LLC
Greenville, South Carolina, United States
Site recruitment: Not reported
The University of Texas Health Science Center at Houston
Bellaire, Texas, United States
Site recruitment: Not reported
Dallas Diabetes Research Center
Dallas, Texas, United States
Site recruitment: Not reported
North Texas Endocrine Center
Dallas, Texas, United States
Site recruitment: Not reported
Biopharma Informatic, LLC
Houston, Texas, United States
Site recruitment: Not reported
North Hills Family Medicine/North Hills Medical Research
North Richland Hills, Texas, United States
Site recruitment: Not reported
Clinical Trials of Texas, Inc.
San Antonio, Texas, United States
Site recruitment: Not reported
Northwest Houston Heart Center
Tomball, Texas, United States
Site recruitment: Not reported
Health Research of Hampton Roads, Inc.
Newport News, Virginia, United States
Site recruitment: Not reported
Capital Clinical Research Center
Olympia, Washington, United States
Site recruitment: Not reported
Rainier Clinical Research Center
Renton, Washington, United States
Site recruitment: Not reported
CEDIC
CABA, Buenos Aires, Argentina
Site recruitment: Not reported
Centro Médico Viamonte
CABA, Buenos Aires, Argentina
Site recruitment: Not reported
Stat Research S.A.
Ciudad Autónoma de Buenos Aire, Buenos Aires, Argentina
Site recruitment: Not reported
Mautalen Salud e Investigación
Buenos Aires, Ciudad Autónoma de Buenos Aire, Argentina
Site recruitment: Not reported
Centro Medico Dr Laura Maffei Investigacion Clinica Aplicada
Ciudad Autonoma de Buenos Aire, Ciudad Autónoma de Buenos Aire, Argentina
Site recruitment: Not reported
Instituto Médico Catamarca IMEC
Rosario, Santa Fe Province, Argentina
Site recruitment: Not reported
Asociación de Beneficencia Hospital Sirio Libanés
Buenos Aires, Argentina
Site recruitment: Not reported
CEDOES
Vitória, Espírito Santo, Brazil
Site recruitment: Not reported
Cline Research Center
Curitiba, Paraná, Brazil
Site recruitment: Not reported
Núcleo de Pesquisa Clínica do Rio Grande do Sul
Porto Alegre, Rio Grande do Sul, Brazil
Site recruitment: Not reported
Centro de Pesquisa Sao Lucas
Campinas, São Paulo, Brazil
Site recruitment: Not reported
ISPEM - Instituto São José dos Campos em Pesquisas Médicas
São José dos Campos, São Paulo, Brazil
Site recruitment: Not reported
BR Trials - Ensaios Clinicos e Consultoria
São Paulo, São Paulo, Brazil
Site recruitment: Not reported
IBPClin - Instituto Brasil de Pesquisa Clínica
Rio de Janeiro, Brazil
Site recruitment: Not reported
CPQuali Pesquisa Clínica
São Paulo, Brazil
Site recruitment: Not reported
Centro de Endocrinologia Alcantara Gonzalez
Bayamón, Puerto Rico
Site recruitment: Not reported
Private Practice Dr. Martha Gomez Cuellar
San Juan, Puerto Rico
Site recruitment: Not reported
Wellness clinical Research Vega Baja
Vega Baja, Puerto Rico
Site recruitment: Not reported
Chung Shan Medical University Hospital
Taichung, Taiwan
Site recruitment: Not reported
China Medical University Hospital
Taichung, Taiwan
Site recruitment: Not reported
National Cheng-Kung Uni. Hosp.
Tainan, Taiwan
Site recruitment: Not reported
National Taiwan University Hospital
Taipei, Taiwan
Site recruitment: Not reported

Original record, eligibility, contacts and results →